Due Diligence and Art

Due Diligence and Art

Home
Notes
Chat
EUA Countermeasures and PREP …
Pandemic Preparedness Racket …
mRNA, Gene Therapies and Biom…
Playbug: Bioweapons Fearporn
Archive
Leaderboard
About

Share this post

Due Diligence and Art
Due Diligence and Art
Mainstream pharma press admits that CRISPR technology failed.
mRNA, Gene Therapies and Biomanufacturing Fraud

Mainstream pharma press admits that CRISPR technology failed.

Moments of honesty from the least expected places should be cherished.

Sasha Latypova's avatar
Sasha Latypova
Mar 28, 2025
∙ Paid
320

Share this post

Due Diligence and Art
Due Diligence and Art
Mainstream pharma press admits that CRISPR technology failed.
118
62
Share
Cross-post from Due Diligence and Art
Hey, maybe we don't have anything to be concerned about. If no one is willing or able to stay in business to make poisonous "therapies", they won't exist. At all. -
Desert Nomad

If you stand on a river bank and wait for failed gene therapies to float by… you will be flooded! Admission of failure from the pharma propaganda outlets, on the other hand, is a rare event. This washed up in my inbox recently:

“Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down.”

Due Diligence and Art is a reader-supp…


Subscribe to Due Diligence and Art to continue reading

Visit the author’s Substack to subscribe and read more.
320

Share this post

Due Diligence and Art
Due Diligence and Art
Mainstream pharma press admits that CRISPR technology failed.
118
62
Share

No posts

© 2025 Sasha Latypova
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share